Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

20%

Ph not_applicable

40%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Detailed Status

Completed4

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (33.3%)

N/A2 (66.7%)

Trials by Status

completed480%

not_yet_recruiting120%

Recent Activity

0 active trials

Showing 5 of 5

not_yet_recruitingnot_applicable

Comparison of Surgical Outcomes of Craniotomy and Craniectomy in Posterior Fossa Lesions

NCT06831695

completed

Prospective, Multicenter Observational Study Evaluating the Long Term Safety of the Custombone Implant

NCT01824706

Clinical Trials (5)

Showing 5 of 5 trials

NCT06831695Not Applicable

Comparison of Surgical Outcomes of Craniotomy and Craniectomy in Posterior Fossa Lesions

Not Yet Recruiting

NCT04745715

Genomic Study in Non-small Cell Lung Cancer Brain Metastasis

Completed

NCT02893137Phase 1

Enhancing Optune Therapy With Targeted Craniectomy

Completed

NCT02033824Not Applicable

Amniotic Membrane in Decompressive Craniectomy to Reduce Scarring

Completed

NCT01824706

Prospective, Multicenter Observational Study Evaluating the Long Term Safety of the Custombone Implant

Completed

All 5 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 5